Evaluating the Safety, Tolerability, and Pharmacokinetics of BIIB095 in Healthy Participants

NCT03454126 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen